OXA-48-Like β-Lactamases: Global Epidemiology, Treatment Options, and Development Pipeline
出版年份 2022 全文链接
标题
OXA-48-Like β-Lactamases: Global Epidemiology, Treatment Options, and Development Pipeline
作者
关键词
-
出版物
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 66, Issue 8, Pages -
出版商
American Society for Microbiology
发表日期
2022-07-20
DOI
10.1128/aac.00216-22
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis
- (2022) Christopher JL Murray et al. LANCET
- To Be or Not to Be an OXA-48 Carbapenemase
- (2022) Laura Dabos et al. Microorganisms
- Massive Spread of OXA-48 Carbapenemase-Producing Enterobacteriaceae in the Environment of a Swiss Companion Animal Clinic
- (2022) Kira Schmitt et al. Antibiotics-Basel
- Characteristics and outcomes of carbapenemase harbouring carbapenem-resistant Klebsiella spp. bloodstream infections: a multicentre prospective cohort study in an OXA-48 endemic setting
- (2022) Burcu Isler et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Carbapenemase-producing Klebsiella pneumoniae strains in Switzerland: human and non-human settings may share high-risk clones
- (2022) Edgar I. Campos-Madueno et al. Journal of Global Antimicrobial Resistance
- Dissemination of a single ST11 clone of OXA-48-producing Klebsiella pneumoniae within a large polyclonal hospital outbreak determined by genomic sequencing
- (2022) Fernando Lázaro-Perona et al. Microbial Genomics
- Municipal Wastewaters Carry Important Carbapenemase Genes Independent of Hospital Input and Can Mirror Clinical Resistance Patterns
- (2022) Adela Teban-Man et al. Microbiology Spectrum
- Occurrence of High Levels of Cefiderocol Resistance in Carbapenem-Resistant Escherichia coli before Its Approval in China: a Report from China CRE-Network
- (2022) Qi Wang et al. Microbiology Spectrum
- Surveillance of Antimicrobial Resistance in Hospital Wastewater: Identification of Carbapenemase-Producing Klebsiella spp.
- (2022) Miguel Galarde-López et al. Antibiotics-Basel
- OXA-181-Like Carbapenemases in Klebsiella pneumoniae ST14, ST15, ST23, ST48, and ST231 from Septicemic Neonates: Coexistence with NDM-5, Resistome, Transmissibility, and Genome Diversity
- (2021) Sharmi Naha et al. mSphere
- A high prevalence of bla OXA-48 in Klebsiella (Raoultella) ornithinolytica and related species in hospital wastewater in South West England
- (2021) Marjorie J. Gibbon et al. Microbial Genomics
- OXA-48 Carbapenemase-Producing Enterobacterales in Spanish Hospitals: An Updated Comprehensive Review on a Rising Antimicrobial Resistance
- (2021) Mario Rivera-Izquierdo et al. Antibiotics-Basel
- Whole-genome sequencing of Egyptian multidrug-resistant Klebsiella pneumoniae isolates: a multi-center pilot study
- (2021) May Sherif et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Cefepime/tazobactam compared with other tazobactam combinations against problem Gram-negative bacteria
- (2021) Shazad MUSHTAQ et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Correlation between the Antibiotic Resistance Genes and Susceptibility to Antibiotics among the Carbapenem-Resistant Gram-Negative Pathogens
- (2021) Salma M. Abdelaziz et al. Antibiotics-Basel
- In Vitro Activity of the Ultrabroad-Spectrum Beta-Lactamase Inhibitor QPX7728 in Combination with Multiple Beta-Lactam Antibiotics against Pseudomonas aeruginosa
- (2021) Olga Lomovskaya et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activity of cefepime/zidebactam (WCK 5222) against ‘problem’ antibiotic-resistant Gram-negative bacteria sent to a national reference laboratory
- (2021) Shazad Mushtaq et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Monitoring of hospital sewage shows both promise and limitations as an early-warning system for carbapenemase-producing Enterobacterales in a low-prevalence setting
- (2021) Carl-Fredrik Flach et al. WATER RESEARCH
- Molecular characteristics of antibiotic-resistant Escherichia coli and Klebsiella pneumoniae strains isolated from hospitalized patients in Tehran, Iran
- (2021) Javad Yasbolaghi Sharahi et al. Annals of Clinical Microbiology and Antimicrobials
- Recent emergence of aztreonam-avibactam resistance in NDM and OXA-48 carbapenemase-producing Escherichia coli in Germany
- (2021) Patrice Nordmann et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Rapid Development of Cefiderocol Resistance in Carbapenem-resistant Enterobacter cloacae During Therapy Is Associated With Heterogeneous Mutations in the Catecholate Siderophore Receptor cirA
- (2021) Sabrina Klein et al. CLINICAL INFECTIOUS DISEASES
- Outbreak of OXA-48-producing Enterobacterales in a haematological ward associated with an uncommon environmental reservoir, France, 2016 to 2019
- (2021) Sarah Jolivet et al. Eurosurveillance
- Increasing frequency of OXA-48-producing Enterobacterales worldwide and activity of ceftazidime/avibactam, meropenem/vaborbactam and comparators against these isolates
- (2021) Mariana Castanheira et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Molecular detection of carbapenem resistance genes in rectal swabs from patients in Gulf Cooperation Council hospitals
- (2021) M. Alqahtani et al. JOURNAL OF HOSPITAL INFECTION
- Genetic characteristics of OXA-48-producing Enterobacterales from China
- (2021) Lifeng Wang et al. Journal of Global Antimicrobial Resistance
- Emergence and genomics of OXA-232-producing Klebsiella pneumoniae in a hospital in Yancheng, China
- (2021) Zhichen Zhu et al. Journal of Global Antimicrobial Resistance
- OXA-48 Carbapenemase-Encoding Transferable Plasmids of Klebsiella pneumoniae Recovered from Egyptian Patients Suffering from Complicated Urinary Tract Infections
- (2021) Ann A. Elshamy et al. Biology-Basel
- Hypervirulent Klebsiella pneumoniae ST23 producing OXA-48 in Switzerland
- (2021) Dominique S. Blanc et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Flomoxef for neonates: extending options for treatment of neonatal sepsis caused by ESBL-producing Enterobacterales
- (2021) Christopher A Darlow et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Repatriation of a patient with COVID-19 contributed to the importation of an emerging carbapenemase producer
- (2021) Aline I. Moser et al. Journal of Global Antimicrobial Resistance
- A retrospective, multicentre evaluation of eravacycline utilisation in community and academic hospitals
- (2021) Athena L.V. Hobbs et al. Journal of Global Antimicrobial Resistance
- Outbreak of Multidrug-Resistant OXA-232-Producing ST15 Klebsiella pneumoniae in a Teaching Hospital in Wenzhou, China
- (2021) Huaiyu Jia et al. Infection and Drug Resistance
- A role for arthropods as vectors of multidrug-resistant Enterobacterales in surgical site infections from South Asia
- (2021) Brekhna Hassan et al. Nature Microbiology
- Fecal Carriage and Molecular Characterization of Carbapenemase-Producing Enterobacterales in the Pediatric Population in Qatar
- (2021) Andrés Pérez-López et al. Microbiology Spectrum
- Genomic Investigation and Successful Containment of an Intermittent Common Source Outbreak of OXA-48-Producing Enterobacter cloacae Related to Hospital Shower Drains
- (2021) Dennis Nurjadi et al. Microbiology Spectrum
- In Vitro Synergism of Azithromycin Combination with Antibiotics against OXA-48-Producing Klebsiella pneumoniae Clinical Isolates
- (2021) Uthaibhorn Singkham-in et al. Antibiotics-Basel
- OXA-181-producing extra-intestinal pathogenic Escherichia coli ST410 isolated from a dog in Portugal
- (2020) Michael Brilhante et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Unorthodox Parenteral β-lactam and β-lactamase Inhibitor Combinations: Flouting Antimicrobial Stewardship and Compromising Patient Care
- (2020) Snehal Palwe et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- ‘CRE, CRO, CPE and CPO’: terminology past its ‘sell-by-date’ in an era of new antibiotics and regional carbapenemase epidemiology
- (2020) David M Livermore et al. CLINICAL INFECTIOUS DISEASES
- Epidemiology of carbapenemase-producing Enterobacterales in the Middle East: a systematic review
- (2020) Abdelaziz Touati et al. Expert Review of Anti-Infective Therapy
- Klebsiella pneumoniae ST307 with OXA-181: threat of a high-risk clone and promiscuous plasmid in a resource-constrained healthcare setting
- (2020) K A Strydom et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- High prevalence of Escherichia coli clinical isolates in India harbouring four amino acid inserts in PBP3 adversely impacting activity of aztreonam/avibactam
- (2020) Hariharan Periasamy et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Core/Whole Genome Multilocus Sequence Typing and Core Genome SNP-Based Typing of OXA-48-Producing Klebsiella pneumoniae Clinical Isolates From Spain
- (2020) Elisenda Miro et al. Frontiers in Microbiology
- Co-existence of OXA-48 and NDM-1 in colistin resistant Pseudomonas aeruginosa ST235
- (2020) Cansel Vatansever et al. Emerging Microbes & Infections
- Biochemical Characterization of QPX7728, a New Ultrabroad-Spectrum Beta-Lactamase Inhibitor of Serine and Metallo-Beta-Lactamases
- (2020) Ruslan Tsivkovski et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of the synergy of ceftazidime/avibactam in combination with colistin, doripenem, levofloxacin, tigecycline, and tobramycin against OXA-48 producing Enterobacterales
- (2020) Emel Mataraci Kara et al. JOURNAL OF CHEMOTHERAPY
- Small Changes in Hydration Determine Cephalosporinase Activity of OXA-48 β-Lactamases
- (2020) Viivi H. A. Hirvonen et al. ACS Catalysis
- In vitro evaluation of double carbapenem and colistin combinations against OXA-48, NDM carbapenemase-producing colistin-resistant Klebsiella pneumoniae strains
- (2020) Fatma Erdem et al. Antimicrobial Resistance and Infection Control
- Metallo-β-lactamases: structure, function, epidemiology, treatment options, and the development pipeline
- (2020) Sara E Boyd et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ongoing dissemination of OXA-244 carbapenemase-producing Escherichia coli in Switzerland and their detection
- (2020) Amandine Masseron et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Activity of cefepime/zidebactam against MDR Escherichia coli isolates harbouring a novel mechanism of resistance based on four-amino-acid inserts in PBP3
- (2020) Sachin S Bhagwat et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Spill-Over from Public Health? First Detection of an OXA-48-Producing Escherichia coli in a German Pig Farm
- (2020) Alexandra Irrgang et al. Microorganisms
- Detection of Carbapenem-Resistance Genes in Klebsiella Species Recovered from Selected Environmental Niches in the Eastern Cape Province, South Africa
- (2020) Kingsley Ehi Ebomah et al. Antibiotics-Basel
- Intrapulmonary Pharmacokinetics of Cefepime and Enmetazobactam in Healthy Volunteers: Towards New Treatments for Nosocomial Pneumonia
- (2020) Shampa Das et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Cross-border emergence of clonal lineages of ST38 Escherichia coli producing the OXA-48-like carbapenemase OXA-244 in Germany and Switzerland
- (2020) Linda Falgenhauer et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Activity of β-lactam/taniborbactam (VNRX-5133) combinations against carbapenem-resistant Gram-negative bacteria
- (2020) Shazad Mushtaq et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial
- (2020) Matteo Bassetti et al. LANCET INFECTIOUS DISEASES
- Plasmid mediated colistin resistant mcr-1 and co-existence of OXA-48 among Escherichia coli from clinical and poultry isolates: first report from Nepal
- (2020) Bijaya Muktan et al. Gut Pathogens
- Comparative Kinetic Analysis of OXA-438 with Related OXA-48-Type Carbapenem-Hydrolyzing Class D β-Lactamases
- (2020) Denise De Belder et al. ACS Infectious Diseases
- Aztreonam/avibactam activity against clinical isolates of Enterobacterales collected in Europe, Asia and Latin America in 2019
- (2020) Helio S Sader et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Multi-clonal spread of Klebsiella pneumoniae across hospitals in Khartoum, Sudan
- (2020) Einas A. Osman et al. Journal of Global Antimicrobial Resistance
- Ceftazidime–Avibactam Resistance Mutations V240G, D179Y, and D179Y/T243M in KPC-3 β-Lactamase Do Not Alter Cefpodoxime–ETX1317 Susceptibility
- (2020) Adam B. Shapiro et al. ACS Infectious Diseases
- Genomic and Resistance Epidemiology of Gram-Negative Bacteria in Africa: a Systematic Review and Phylogenomic Analyses from a One Health Perspective
- (2020) John Osei Sekyere et al. mSystems
- Antimicrobial Resistance and Genomic Characterization of OXA-48- and CTX-M-15-Co-Producing Hypervirulent Klebsiella pneumoniae ST23 Recovered from Nosocomial Outbreak
- (2020) Elvira Shaidullina et al. Antibiotics-Basel
- OXA-48-Mediated Ceftazidime-Avibactam Resistance Is Associated with Evolutionary Trade-Offs
- (2019) Christopher Fröhlich et al. mSphere
- Nationwide epidemiology of carbapenem resistant Klebsiella pneumoniae isolates from Greek hospitals, with regards to plazomicin and aminoglycoside resistance
- (2019) Irene Galani et al. BMC INFECTIOUS DISEASES
- In vitro activity of cefepime-enmetazobactam against Gram-negative isolates collected from United States and European hospitals during 2014-2015
- (2019) Ian Morrissey et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Introduction of NDM-1 and OXA-370 from Brazil into Chile in strains of Klebsiella pneumoniae isolated from a single patient
- (2019) Sergio Carrasco-Anabalón et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Rapidly disseminating blaOXA-232 carrying Klebsiella pneumoniae belonging to ST231 in India: multiple and varied mobile genetic elements
- (2019) Chaitra Shankar et al. BMC MICROBIOLOGY
- Efficacy of ceftazidime-avibactam in the treatment of infections due to Carbapenem-resistant Enterobacteriaceae
- (2019) Basem M. Alraddadi et al. BMC INFECTIOUS DISEASES
- Shedding of OXA-181 carbapenemase-producing Escherichia coli from companion animals after hospitalisation in Switzerland: an outbreak in 2018
- (2019) Aurélien Nigg et al. Eurosurveillance
- β-lactam resistance genes in bacteriophage and bacterial DNA from wastewater, river water, and irrigation water in Washington State
- (2019) Anyun Zhang et al. WATER RESEARCH
- Sequence-Based Epidemiology of an OXA-48 Plasmid during a Hospital Outbreak
- (2019) Laura Hidalgo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Nosocomial spread of OXA-232-producing Klebsiella pneumoniae ST15 in a teaching hospital, Shanghai, China
- (2019) Xin Li et al. BMC MICROBIOLOGY
- Treatment Options for Carbapenem-resistant Gram-negative Bacterial Infections
- (2019) Yohei Doi CLINICAL INFECTIOUS DISEASES
- The Global Ascendency of OXA-48-Type Carbapenemases
- (2019) Johann D. D. Pitout et al. CLINICAL MICROBIOLOGY REVIEWS
- Emergence of Klebsiella pneumoniae and Enterobacter cloacae producing OXA-48 carbapenemases from retail meats in China, 2018
- (2019) Zilin Zhuang et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Detection of OXA-48-like-producing Enterobacterales in Irish recreational water
- (2019) Bláthnaid M. Mahon et al. SCIENCE OF THE TOTAL ENVIRONMENT
- Pathogenicity of Clinical OXA-48 Isolates and Impact of the OXA-48 IncL Plasmid on Virulence and Bacterial Fitness
- (2019) Axel Hamprecht et al. Frontiers in Microbiology
- In Vitro Activity of Eravacycline against Gram-Negative Bacilli Isolated in Clinical Laboratories Worldwide from 2013 to 2017
- (2019) Ian Morrissey et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- VNRX-5133 (Taniborbactam), a Broad-Spectrum Inhibitor of Serine- and Metallo-β-Lactamases, Restores Activity of Cefepime in Enterobacterales and Pseudomonas aeruginosa
- (2019) Jodie C. Hamrick et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The difficulties of identifying and treating Enterobacterales with OXA-48-like carbapenemases
- (2019) J.M. Kidd et al. CLINICAL MICROBIOLOGY AND INFECTION
- Biochemical and Structural Characterization of OXA-405, an OXA-48 Variant with Extended-Spectrum β-Lactamase Activity
- (2019) Saoussen Oueslati et al. Microorganisms
- Genetic support of carbapenemases in double carbapenemase producer Klebsiella pneumoniae isolated in the Arabian Peninsula
- (2018) Amna E. Al-Baloushi et al. ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA
- Diversity of carbapenemase-producing Escherichia coli isolates, France 2012-2013
- (2018) Lauraine Gauthier et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Carbapenemase-producing Enterobacteriaceae in Mexico: report of seven non-clonal cases in a pediatric hospital
- (2018) Alejandra Aquino-Andrade et al. BMC MICROBIOLOGY
- Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae
- (2018) Jesús Rodríguez-Baño et al. CLINICAL MICROBIOLOGY REVIEWS
- Shewanella species as the origin of bla OXA-48 genes: insights into gene diversity, associated phenotypes and possible transfer mechanisms
- (2018) Marta Tacão et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Clonal emergence of Klebsiella pneumoniae ST14 co-producing OXA-48-type and NDM carbapenemases with high rate of colistin resistance in Dubai, United Arab Emirates
- (2018) Carole Ayoub Moubareck et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Geographical and temporal clustering of OXA-48-producing Escherichia coli ST410 causing community-onset urinary tract infection in Christchurch, New Zealand
- (2018) J C Howard et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- OUP accepted manuscript
- (2018) JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- OUP accepted manuscript
- (2018) JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Emerge of bla NDM-1 and bla OXA-48-like harboring carbapenem-resistant Klebsiella pneumoniae isolates from hospitalized patients in southwestern Iran
- (2018) Zahra Hosseinzadeh et al. Journal of the Chinese Medical Association
- Characterization of Carbapenemase-Producing Enterobacteriaceae from Patients in Amman, Jordan
- (2018) Amin Abdelfattah Aqel et al. Microbial Drug Resistance
- High Prevalence of Multidrug-Resistant Bacteria in Libyan War Casualties Admitted to a Tertiary Care Hospital, Germany
- (2018) Benedikt Lohr et al. Microbial Drug Resistance
- The emergence of carbapenem-resistant Klebsiella pneumoniae isolates producing OXA-48 and NDM in the Southern (Asir) province, Saudi Arabia
- (2018) Ibrahim Al-Zahrani et al. SAUDI MEDICAL JOURNAL
- Comparative analysis of Klebsiella pneumoniae strains isolated in 2012–2016 that differ by antibiotic resistance genes and virulence genes profiles
- (2018) Anastasia I. Lev et al. Pathogens and Global Health
- Multispecies and Clonal Dissemination of OXA-48 Carbapenemase in Enterobacteriaceae From Companion Animals in Germany, 2009—2016
- (2018) Sandra Pulss et al. Frontiers in Microbiology
- Clonal dissemination of OXA-48-producing Enterobacter cloacae isolates from companion animals in Algeria
- (2018) Massilia Yousfi et al. Journal of Global Antimicrobial Resistance
- Treatment of Infections with OXA-48 producing Enterobacteriaceae
- (2018) Adam Stewart et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In vitro activity of ceftazidime-avibactam and aztreonam-avibactam against OXA-48-carrying Enterobacteriaceae isolated as part of the International Network for Optimal Resistance Monitoring (INFORM) global surveillance program, 2012 to 2015
- (2018) Krystyna M. Kazmierczak et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Post Syrian war impact on susceptibility rates and trends in molecular characterization of Enterobacteriaceae
- (2018) Aline Hajj et al. Future Microbiology
- Providencia rettgeri’de OXA-48 ve NDM-1 Karbapenemaz Genlerinin Birlikte Üretimi: İlk Bildirim
- (2018) Barış OTLU et al. MIKROBIYOLOJI BULTENI
- ARGONAUT-I: Activity of Cefiderocol (S-649266), a Siderophore Cephalosporin, against Gram-Negative Bacteria, Including Carbapenem-Resistant Nonfermenters and Enterobacteriaceae with Defined Extended-Spectrum β-Lactamases and Carbapenemases
- (2018) Michael R. Jacobs et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- IGNITE4: Results of a Phase 3, Randomized, Multicenter, Prospective Trial of Eravacycline vs. Meropenem in the Treatment of Complicated Intra-Abdominal Infections
- (2018) Joseph S Solomkin et al. CLINICAL INFECTIOUS DISEASES
- Sink traps as the source of transmission of OXA-48–producing Serratia marcescens in an intensive care unit
- (2018) Gili Regev-Yochay et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Stability of cefiderocol against clinically significant broad-spectrum oxacillinases
- (2018) Laurent Poirel et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Abundance of carbapenemase genes ( bla KPC , bla NDM and bla OXA-48 ) in wastewater effluents from Tunisian hospitals
- (2017) Emna Nasri et al. ENVIRONMENTAL POLLUTION
- Dissemination of bla OXA-370 gene among several Enterobacteriaceae species in Brazil
- (2017) C. M. Magagnin et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- OXA-48-like carbapenemases producing Enterobacteriaceae in different niches
- (2017) Assia Mairi et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Analysis of OXA-204 carbapenemase-producing Enterobacteriaceae reveals possible endoscopy-associated transmission, France, 2012 to 2014
- (2017) Anaïs Potron et al. Eurosurveillance
- Emergence of carbapenem resistant Escherichia coli isolates producing bla NDM and bla OXA-48 -like carried on IncA/C and IncL/M plasmids at two Iranian university hospitals
- (2017) Hamid Solgi et al. INFECTION GENETICS AND EVOLUTION
- Clinical efficacy of ceftazidime/avibactam versus other active agents for the treatment of bacteremia due to carbapenemase-producing Enterobacteriaceae in hematologic patients
- (2017) Juan J. Castón et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Activity of ceftazidime/avibactam against problem Enterobacteriaceae and Pseudomonas aeruginosa in the UK, 2015–16
- (2017) David M Livermore et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Colistin- and carbapenem-resistant Klebsiella pneumoniae carrying mcr-1 and blaOXA-48 isolated at a paediatric hospital in Vietnam
- (2017) Björn Berglund et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- WCK 5222 (cefepime/zidebactam) antimicrobial activity tested against Gram-negative organisms producing clinically relevant β-lactamases
- (2017) Helio S. Sader et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In vitro activity of cefepime/zidebactam (WCK 5222) against Gram-negative bacteria
- (2017) David M. Livermore et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Activity of ceftolozane/tazobactam against surveillance and ‘problem’ Enterobacteriaceae, Pseudomonas aeruginosa and non-fermenters from the British Isles
- (2017) David M. Livermore et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- OXA-48-like carbapenemases in the UK: an analysis of isolates and cases from 2007 to 2014
- (2017) Jacqueline Findlay et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Characterization of OXA-48-like carbapenemase producers in Canada, 2011–14
- (2017) Laura F Mataseje et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace
- (2017) Latania K. Logan et al. JOURNAL OF INFECTIOUS DISEASES
- Culture-independent methods reveal high diversity of OXA-48-like genes in water environments
- (2017) Marta Tacão et al. JOURNAL OF WATER AND HEALTH
- Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study
- (2017) Belén Gutiérrez-Gutiérrez et al. LANCET INFECTIOUS DISEASES
- Characterization of OXA-48-like-producing Enterobacteriaceae isolated from river water in Algeria
- (2017) Rima Tafoukt et al. WATER RESEARCH
- First Report of German Cockroaches (Blattella germanica) as Reservoirs of CTX-M-15 Extended-Spectrum-β-Lactamase- and OXA-48 Carbapenemase-Producing Enterobacteriaceae in Batna University Hospital, Algeria
- (2016) Lotfi Loucif et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ceftazidime-avibactam as salvage therapy for infections caused by carbapenem-resistant organisms: a case series from the compassionate-use program
- (2016) Elizabeth Temkin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Molecular characterization of OXA-48-like-producing Enterobacteriaceae in the Czech Republic: evidence for horizontal transfer of pOXA-48-like plasmids
- (2016) Anna Skálová et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ceftazidime/Avibactam and Ceftolozane/Tazobactam: Second-generation β-Lactam/β-Lactamase Inhibitor Combinations
- (2016) David van Duin et al. CLINICAL INFECTIOUS DISEASES
- Emergence of Klebsiella pneumoniae co-producing OXA-48, CTX-M-15, and ArmA in Greece
- (2016) I. Galani et al. CLINICAL MICROBIOLOGY AND INFECTION
- Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent
- (2016) George G. Zhanel et al. DRUGS
- National survey of colistin resistance among carbapenemase-producingEnterobacteriaceaeand outbreak caused by colistin-resistant OXA-48-producingKlebsiella pneumoniae, France, 2014
- (2016) Aurélie Jayol et al. Eurosurveillance
- Treatment options for extended-spectrum beta-lactamase (ESBL) and AmpC-producing bacteria
- (2016) Ryan G. D’Angelo et al. EXPERT OPINION ON PHARMACOTHERAPY
- OXA-48-producing ST372Escherichia coliin a French dog
- (2016) Luana C. Melo et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Rapid Identification of OXA-48 and OXA-163 Subfamilies in Carbapenem-Resistant Gram-Negative Bacilli with a Novel Immunochromatographic Lateral Flow Assay
- (2016) Fernando Pasteran et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Emergence of Carbapenemase-ProducingEscherichia coliIsolated from Companion Animals in Algeria
- (2016) Massilia Yousfi et al. Microbial Drug Resistance
- Occurrence of OXA-48 Carbapenemase and Other β-Lactamase Genes in ESBL-Producing Multidrug Resistant Escherichia coli from Dogs and Cats in the United States, 2009–2013
- (2016) Xiaoqiang Liu et al. Frontiers in Microbiology
- Nosocomial Outbreak of OXA-48-Producing Klebsiella pneumoniae in a Chinese Hospital: Clonal Transmission of ST147 and ST383
- (2016) Ling Guo et al. PLoS One
- Genetic and Biochemical Characterization of OXA-405, an OXA-48-Type Extended-Spectrum β-Lactamase without Significant Carbapenemase Activity
- (2015) Laurent Dortet et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- First Report of Ceftazidime-Avibactam Resistance in a KPC-3-Expressing Klebsiella pneumoniae Isolate
- (2015) Romney M. Humphries et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- What Is the Appropriate Meropenem MIC for Screening of Carbapenemase-Producing Enterobacteriaceae in Low-Prevalence Settings?
- (2015) Ramzi Fattouh et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Detection and characterization of carbapenemase-producing Enterobacteriaceae in wounded Syrian patients admitted to hospitals in northern Israel
- (2015) A. Lerner et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Carbapenemase-producingEnterobacteriaceaein Europe: assessment by national experts from 38 countries, May 2015
- (2015) Barbara Albiger et al. Eurosurveillance
- Forecasting carbapenem resistance from antimicrobial consumption surveillance: Lessons learnt from an OXA-48-producing Klebsiella pneumoniae outbreak in a West London renal unit
- (2015) M. Gharbi et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- OXA-48-Producing Enterobacteriaceae Causing Bacteremia, United Arab Emirates
- (2015) Chulsoo Ahn et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- In vitroantimicrobial activity of S-649266, a catechol-substituted siderophore cephalosporin, when tested against non-fermenting Gram-negative bacteria
- (2015) Akinobu Ito et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Heterogeneous hydrolytic features for OXA-48-like -lactamases
- (2015) S. Oueslati et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In vitroevaluation of dual carbapenem combinations against carbapenemase-producing Enterobacteriaceae
- (2015) Laurent Poirel et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Factors Associated to Prevalence and Incidence of Carbapenem-Resistant Enterobacteriaceae Fecal Carriage: A Cohort Study in a Mexican Tertiary Care Hospital
- (2015) Pedro Torres-Gonzalez et al. PLoS One
- In vitro activities of colistin, tigecycline and tobramycin, alone or in combination, against carbapenem-resistant Enterobacteriaceae strains
- (2015) Berna Ozbek et al. Journal of Global Antimicrobial Resistance
- Emergence of Escherichia coli producing OXA-48 β-lactamase in the community in Switzerland
- (2015) Katrin Zurfluh et al. Antimicrobial Resistance and Infection Control
- First detection of Klebsiella variicola producing OXA-181 carbapenemase in fresh vegetable imported from Asia to Switzerland
- (2015) K. Zurfluh et al. Antimicrobial Resistance and Infection Control
- An outbreak of carbapenem-resistant OXA-48 – producing Klebsiella pneumonia associated to duodenoscopy
- (2015) Axel Kola et al. Antimicrobial Resistance and Infection Control
- Notes from the Field: Carbapenem-resistant Enterobacteriaceae Producing OXA-48-like Carbapenemases — United States, 2010–2015
- (2015) Meghan Lyman et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Detection of OXA-370, an OXA-48-Related Class D β-Lactamase, in Enterobacter hormaechei from Brazil
- (2014) Jorge L. M. Sampaio et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Crystal Structure of Carbapenemase OXA-58 from Acinetobacter baumannii
- (2014) Clyde A. Smith et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- OXA-48 Carbapenemase-Producing Salmonella enterica Serovar Kentucky Isolate of Sequence Type 198 in a Patient Transferred from Libya to Switzerland
- (2014) Salome N. Seiffert et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Emergence of OXA-48-Producing Escherichia coli Clone ST38 in Fowl
- (2014) Charbel Al Bayssari et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multiresistant extended-spectrum β-lactamase-producing Enterobacteriaceae from humans, companion animals and horses in central Hesse, Germany
- (2014) Judith Schmiedel et al. BMC MICROBIOLOGY
- The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide
- (2014) P. Nordmann et al. CLINICAL MICROBIOLOGY AND INFECTION
- Successful control of a hospital-wide outbreak of OXA-48 producing Enterobacteriaceae in the Netherlands, 2009 to 2011
- (2014) M J Dautzenberg et al. Eurosurveillance
- The role of tigecycline in the treatment of infections in light of the new black box warning
- (2014) Deepali Dixit et al. Expert Review of Anti-Infective Therapy
- Blood stream infections due to OXA-48-like carbapenemase-producing Enterobacteriaceae: treatment and survival
- (2014) Ilker Inanç Balkan et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- The spread of carbapenemase-producing bacteria in Africa: a systematic review
- (2014) Rendani I. Manenzhe et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Efficacy of Humanized Carbapenem and Ceftazidime Regimens against Enterobacteriaceae Producing OXA-48 Carbapenemase in a Murine Infection Model
- (2013) Dora E. Wiskirchen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Derepressed Transfer Properties Leading to the Efficient Spread of the Plasmid Encoding Carbapenemase OXA-48
- (2013) Anaïs Potron et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antibiotic Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae: Systematic Evaluation of the Available Evidence
- (2013) Matthew E. Falagas et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- OXA-181-producing Klebsiella pneumoniae establishing in Singapore
- (2013) Michelle N D Balm et al. BMC INFECTIOUS DISEASES
- Structural Basis for Carbapenemase Activity of the OXA-23 β-Lactamase from Acinetobacter baumannii
- (2013) Clyde A. Smith et al. CHEMISTRY & BIOLOGY
- Colonization of Libyan civil war casualties with multidrug-resistant bacteria
- (2013) K. Koole et al. CLINICAL MICROBIOLOGY AND INFECTION
- KPC-2 and OXA-48 carbapenemase-harbouring Enterobacteriaceae detected in an Austrian wastewater treatment plant
- (2013) H. Galler et al. CLINICAL MICROBIOLOGY AND INFECTION
- In vitro activity of fosfomycin in combination with imipenem, meropenem, colistin and tigecycline against OXA 48–positive Klebsiella pneumoniae strains
- (2013) Ebru Evren et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Intercontinental spread of OXA-48 beta-lactamase-producing Enterobacteriaceae over a 11-year period, 2001 to 2011
- (2013) A Potron et al. Eurosurveillance
- Genetic and biochemical characterisation of OXA-232, a carbapenem-hydrolysing class D β-lactamase from Enterobacteriaceae
- (2013) Anaïs Potron et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- The emergence of OXA-48- and NDM-1-positive Klebsiella pneumoniae in Riyadh, Saudi Arabia
- (2013) Atef Shibl et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- First Report of OXA-48 Carbapenemase-Producing Klebsiella pneumoniae and Escherichia coli in Japan from a Patient Returned from Southeast Asia
- (2013) Noriyuki Nagano et al. JAPANESE JOURNAL OF INFECTIOUS DISEASES
- Emergence of OXA-48 carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in dogs
- (2013) I. Stolle et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Molecular characterization of carbapenem-resistant Klebsiella pneumoniae in a tertiary university hospital in Turkey
- (2013) E. Alp et al. JOURNAL OF HOSPITAL INFECTION
- Injured Libyan combatant patients: both vectors and victims of multiresistance bacteria?
- (2013) Libyan Journal of Medicine
- Whole Genome Sequence Analysis of the First Australian OXA-48-Producing Outbreak-Associated Klebsiella pneumoniae Isolates: The Resistome and In Vivo Evolution
- (2013) Björn A. Espedido et al. PLoS One
- Escherichia coli from Italy Producing OXA-48 Carbapenemase Encoded by a Novel Tn1999Transposon Derivative
- (2012) Tommaso Giani et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Characterization of OXA-204, a Carbapenem-Hydrolyzing Class D β-Lactamase from Klebsiella pneumoniae
- (2012) Anaïs Potron et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Broad-Spectrum β-Lactam Antibiotics for Treating Experimental Peritonitis in Mice Due to Klebsiella pneumoniae Producing the Carbapenemase OXA-48
- (2012) Olivier Mimoz et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Target- and Resistance-Based Mechanistic Studies with TP-434, a Novel Fluorocycline Antibiotic
- (2012) Trudy H. Grossman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy
- (2012) M. Tumbarello et al. CLINICAL INFECTIOUS DISEASES
- Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe
- (2012) R. Cantón et al. CLINICAL MICROBIOLOGY AND INFECTION
- NDM-1, OXA-48 and OXA-181 carbapenemase-producing Enterobacteriaceae in Sultanate of Oman
- (2012) L. Dortet et al. CLINICAL MICROBIOLOGY AND INFECTION
- Bacteraemia due to OXA-48-carbapenemase-producing Enterobacteriaceae: a major clinical challenge
- (2012) C. Navarro-San Francisco et al. CLINICAL MICROBIOLOGY AND INFECTION
- Infections caused by OXA-48-producing Klebsiella pneumoniae in a tertiary hospital in Spain in the setting of a prolonged, hospital-wide outbreak
- (2012) J. R. Pano-Pardo et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- A mosaic transposon encoding OXA-48 and CTX-M-15: towards pan-resistance
- (2012) A. Potron et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Emergence of OXA-48-producing Klebsiella pneumoniae and the novel carbapenemases OXA-244 and OXA-245 in Spain
- (2012) J. Oteo et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- OXA-48-like carbapenemases: the phantom menace
- (2012) L. Poirel et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Emergence of OXA-48 and OXA-181 Carbapenemases among Enterobacteriaceae in South Africa and Evidence ofIn VivoSelection of Colistin Resistance as a Consequence of Selective Decontamination of the Gastrointestinal Tract
- (2012) Adrian J. Brink et al. JOURNAL OF CLINICAL MICROBIOLOGY
- OXA-162, a novel variant of OXA-48 displays extended hydrolytic activity towards imipenem, meropenem and doripenem
- (2012) Murat Kasap et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Emergence of carbapenem-resistant OXA-48 carbapenemase-producing Enterobacteriaceae in Tunisia
- (2012) M. Saidani et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Characterization of OXA-181, a Carbapenem-Hydrolyzing Class D β-Lactamase from Klebsiella pneumoniae
- (2011) Anaïs Potron et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Occurrence of the Carbapenem-Hydrolyzing β-Lactamase GeneblaOXA-48in the Environment in Morocco
- (2011) Anaïs Potron et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Outbreak of OXA-48-Positive Carbapenem-Resistant Klebsiella pneumoniae Isolates in France
- (2011) Gaelle Cuzon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Genetic Features of the Widespread Plasmid Coding for the Carbapenemase OXA-48
- (2011) Laurent Poirel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- OXA-163, an OXA-48-Related Class D β-Lactamase with Extended Activity Toward Expanded-Spectrum Cephalosporins
- (2011) Laurent Poirel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Carbapenems: Past, Present, and Future
- (2011) Krisztina M. Papp-Wallace et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Carbapenem-hydrolyzing class D β-lactamase OXA-48 in Klebsiella pneumoniae isolates from Tunisia
- (2011) H. Lahlaoui et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Introduction of OXA-48-producing Enterobacteriaceae to Israeli hospitals by medical tourism
- (2011) Amos Adler et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Activities of NXL104 Combinations with Ceftazidime and Aztreonam against Carbapenemase-ProducingEnterobacteriaceae
- (2010) David M. Livermore et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Spread of OXA-48-Encoding Plasmid in Turkey and Beyond
- (2010) A. Carrer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Plasmid-mediated carbapenem-hydrolysing OXA-48 β-lactamase in Klebsiella pneumoniae from Tunisia
- (2010) Gaelle Cuzon et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- In Vitro Activity of NXL104 in Combination with -Lactams against Klebsiella pneumoniae Isolates Producing KPC Carbapenemases
- (2009) A. Endimiani et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Diversity, Epidemiology, and Genetics of Class D -Lactamases
- (2009) L. Poirel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Updated Functional Classification of -Lactamases
- (2009) K. Bush et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Crystal Structure of the OXA-48 β-Lactamase Reveals Mechanistic Diversity among Class D Carbapenemases
- (2009) Jean-Denis Docquier et al. CHEMISTRY & BIOLOGY
- In vitro activity of the -lactamase inhibitor NXL104 against KPC-2 carbapenemase and Enterobacteriaceae expressing KPC carbapenemases
- (2009) T. Stachyra et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Acinetobacter radioresistens as a Silent Source of Carbapenem Resistance for Acinetobacter spp.
- (2008) L. Poirel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Plasmid-Encoded Carbapenem-Hydrolyzing -Lactamase OXA-48 in an Imipenem-Susceptible Klebsiella pneumoniae Strain from Belgium
- (2008) G. Cuzon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Spread of OXA-48-Positive Carbapenem-Resistant Klebsiella pneumoniae Isolates in Istanbul, Turkey
- (2008) A. Carrer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Oxacillinase-mediated resistance to carbapenems in Klebsiella pneumoniae from Lebanon
- (2008) G.M. Matar et al. CLINICAL MICROBIOLOGY AND INFECTION
- NXL104 combinations versus Enterobacteriaceae with CTX-M extended-spectrum -lactamases and carbapenemases
- (2008) D. M. Livermore et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started